创新链/学科链/研发链/产业链

新药研发前沿动态 / 医药领域趋势进展

column
Recent Progress of Computer-Aided Drug Designing in the Exploration of Androgen Receptor Dynamic Mechanisms and Drug Discovery
FU Weitao, KE Di, LI Dan, HOU Tingjun
2023, 47(8): 564-577. DOI: 10.20053/j.issn1001-5094.2023.08.002
Abstract PDF
Recent Development in Nuclear Receptor-Targeted Small Molecule Drugs against Prostate Cancer
YUAN Leer, LIAO Jinbiao, CAI-LYU Tao, HU-CHEN Xian, YANG Haodong, SHENG Rong
2023, 47(8): 578-592. DOI: 10.20053/j.issn1001-5094.2023.08.003
Abstract PDF
Advances in Anti-prostate Cancer-Related Nuclear Receptors and Small Molecule Drugs
LU Zhifang, WU Tong, WU Xishan, LI Junhua, ZHANG Yan, LIU Yang, ZHAI Xin, XU Yong
2023, 47(8): 593-607. DOI: 10.20053/j.issn1001-5094.2023.08.004
Abstract PDF
Current Status and Prospects of Clinical Anti-prostate Cancer Nuclear Receptor-Targeted Drugs
WANG He, WANG Song, LI Fangyin
2023, 47(8): 608-616. DOI: 10.20053/j.issn1001-5094.2023.08.005
Abstract PDF
Research Progress and Market Analysis of Androgen Receptor Antagonists for the Treatment of Prostate Cancer
WANG Honglian, WANG Ningning, CHU Dingjun
2023, 47(8): 617-625. DOI: 10.20053/j.issn1001-5094.2023.08.006
Abstract PDF
Research Progress of Sphingosine-1-Phosphate Receptor 1 Selective Modulators
WANG Qianqian, JIANG Cheng
2023, 47(8): 626-636. DOI: 10.20053/j.issn1001-5094.2023.08.007
Abstract PDF
Research Progress of Bone-Targeting Drug Delivery System
ZHANG Mingxiao, SUN Chunmeng
2023, 47(8): 637-644. DOI: 10.20053/j.issn1001-5094.2023.08.008
Abstract PDF